Aier Eye Hospital Group Co., Ltd. (SHE: 300015)
China
· Delayed Price · Currency is CNY 9.52
+0.21 (2.26%)
Sep 9, 2024, 1:59 PM CST
Aier Eye Hospital Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 3,696 | 3,359 | 2,524 | 2,323 | 1,724 | 1,379 | Upgrade
|
| Depreciation & Amortization | 1,414 | 1,327 | 1,166 | 951.72 | 415.92 | 352.32 | Upgrade
|
| Other Amortization | 352.27 | 338.78 | 224.17 | 173.07 | 134.45 | 152.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -6.39 | -0.71 | 1.25 | -0.05 | -0.93 | 0.97 | Upgrade
|
| Asset Writedown & Restructuring Costs | 390.68 | 389.72 | 100.34 | 220.94 | 365.93 | 317.63 | Upgrade
|
| Loss (Gain) From Sale of Investments | -190.89 | 32.9 | 315.49 | 343.61 | 147.23 | -84.09 | Upgrade
|
| Provision & Write-off of Bad Debts | 91.39 | 107.44 | 77.27 | 97.89 | 90.53 | 68.38 | Upgrade
|
| Other Operating Activities | 478.36 | 443.31 | 203.62 | 234.42 | 328.99 | 136.57 | Upgrade
|
| Change in Accounts Receivable | -33.48 | -264.53 | -68.21 | -109.44 | -132.39 | -271.84 | Upgrade
|
| Change in Inventory | 14.8 | -168.65 | -159.47 | -37.58 | -38.91 | 8.98 | Upgrade
|
| Change in Accounts Payable | -1,028 | 136.05 | -48.99 | -206.86 | 342.25 | 17.86 | Upgrade
|
| Change in Other Net Operating Assets | 115.72 | 145.39 | 228.44 | 126.8 | 0.97 | 2.93 | Upgrade
|
| Operating Cash Flow | 5,346 | 5,872 | 4,491 | 4,084 | 3,344 | 2,078 | Upgrade
|
| Operating Cash Flow Growth | -3.57% | 30.76% | 9.95% | 22.15% | 60.87% | 48.47% | Upgrade
|
| Capital Expenditures | -1,813 | -1,460 | -1,388 | -1,494 | -893.71 | -745.63 | Upgrade
|
| Sale of Property, Plant & Equipment | 5.16 | 5.55 | 7.81 | 6.37 | 5.44 | 5.94 | Upgrade
|
| Cash Acquisitions | -2,174 | -1,586 | -1,126 | -945.53 | -30.05 | -957 | Upgrade
|
| Divestitures | - | - | 0.18 | - | - | - | Upgrade
|
| Investment in Securities | 363.07 | -305.88 | -795.67 | -250.32 | -317.18 | -158.85 | Upgrade
|
| Other Investing Activities | 158.67 | 41.75 | 42.4 | 169.16 | 178.33 | 96.44 | Upgrade
|
| Investing Cash Flow | -3,460 | -3,304 | -3,260 | -2,514 | -1,057 | -1,759 | Upgrade
|
| Long-Term Debt Issued | - | 863.31 | 438.21 | 720.32 | 2,610 | 2,846 | Upgrade
|
| Long-Term Debt Repaid | - | -1,422 | -2,350 | -1,170 | -3,045 | -2,048 | Upgrade
|
| Net Debt Issued (Repaid) | -341.31 | -559.03 | -1,912 | -449.79 | -435.2 | 798 | Upgrade
|
| Issuance of Common Stock | 1.08 | - | 3,852 | 1,296 | 693.12 | - | Upgrade
|
| Repurchase of Common Stock | -280.82 | -576.16 | -5.1 | -3.18 | -2.13 | - | Upgrade
|
| Common Dividends Paid | -1,422 | -746.9 | -672.56 | -662.5 | -530.73 | -514.1 | Upgrade
|
| Other Financing Activities | -671.75 | -627.63 | -872.55 | -420.08 | -576.68 | -119.49 | Upgrade
|
| Financing Cash Flow | -2,715 | -2,510 | 390.43 | -239.62 | -851.62 | 164.41 | Upgrade
|
| Foreign Exchange Rate Adjustments | 11.53 | 34.84 | 21.71 | 10.39 | -9.92 | 4.13 | Upgrade
|
| Net Cash Flow | -817.11 | 92.57 | 1,643 | 1,340 | 1,425 | 487.88 | Upgrade
|
| Free Cash Flow | 3,533 | 4,412 | 3,102 | 2,590 | 2,450 | 1,333 | Upgrade
|
| Free Cash Flow Growth | -14.65% | 42.22% | 19.78% | 5.72% | 83.82% | 126.21% | Upgrade
|
| Free Cash Flow Margin | 17.10% | 21.66% | 19.26% | 17.27% | 20.57% | 13.34% | Upgrade
|
| Free Cash Flow Per Share | 0.38 | 0.48 | 0.34 | 0.29 | 0.27 | 0.15 | Upgrade
|
| Cash Income Tax Paid | 1,231 | 1,167 | 1,052 | 1,061 | 616.1 | 565.63 | Upgrade
|
| Levered Free Cash Flow | 2,652 | 3,107 | 2,611 | 3,045 | 2,137 | 1,567 | Upgrade
|
| Unlevered Free Cash Flow | 2,787 | 3,229 | 2,722 | 3,148 | 2,184 | 1,610 | Upgrade
|
| Change in Net Working Capital | 526.36 | 386.7 | -61.82 | -877.12 | -462.5 | -392.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.